Compliance Investigations & White Collar

Kaiser to Present on Enforcement Trends at PLI
October 1, 2021 | Compliance Investigations & White Collar
On October 5, Geoffrey R. Kaiser will be part of PLI’s Life Sciences 2021: Navigating Legal Challenges in Drug and Device Industries. Jeff will be a panelist on the program, Enforcement Trends impacting the Drug and Device Industries, which will cover the following topics: False Claims Act Anti-Kickback Statute Off-Label Promotion Individual Liability For information and …
Read More
Ullman Comments on Phenibut Usage Research Result
September 22, 2021 | Compliance Investigations & White Collar
Marc Ullman was quoted in the article, “Cohen-led team concludes phenibut warnings had no deterrent effect.” The article explains how Dr. Pieter Cohen’s team did research on dietary supplements that contained phenibut in 2017, and found that not only did the companies continue using the ingredient in 2019 after being issued warning letters from …
Read More
Ullman Opines on Characterization of Synthetic Glycans
September 9, 2021 | Compliance Investigations & White Collar
Marc Ullman was interviewed for the Nutraingredients-USA article, “Synthetic glycans developer issued warning over failure to file IND in COVID-19 trials.” The Food & Drug Administration (FDA) issued a warning letter to Kaleido for the way they set up trials for its synthetic glycans product. The FDA’s position was that the trials were attempting to …
Read More
35 Rivkin Radler Attorneys Named to Best Lawyers in America®/ Best Lawyers: Ones to Watch for 2022
August 19, 2021 | Construction | Tax | Corporate | Intellectual Property | Insurance Fraud | Insurance Coverage | Health Services | Employment & Labor | Commercial Litigation | Compliance Investigations & White Collar | Trusts & Estates | Real Estate, Zoning & Land Use
Uniondale, New York – August 19, 2021 – The prestigious Best Lawyers in America has again included Rivkin Radler LLP in its U.S. rankings for 2022. For the first time, the firm was recognized in the areas of tax and technology. One Rivkin attorney, based in Albany, has been named Lawyer of the Year: Richard …
Read More
Shapiro Featured in ‘Short Legal Briefs with Josh Long’
August 16, 2021 | Compliance Investigations & White Collar
Steven Shapiro participated in a webinar hosted by Informa Markets, entitled “Short Legal Briefs with Josh Long.” The webinar presented the case against amending the Federal Food Drug and Cosmetic Act to require companies to submit all dietary supplement product labels to the Food and Drug Administration. “Short Legal Briefs with Josh Long,” describes itself …
Read More
Rivkin Radler Lunch-and-Learn Series: Responding to Information Requests from Payers and Regulators
July 27, 2021 | Compliance Investigations & White Collar | Health Services
Please join us as Rivkin Radler partners Christopher J. Kutner and John Queenan present how to think through information requests to construct the proper response. Program overview: • State and federal agency requests • Payor requests (Medicare, Medicaid, and commercial) • Disclosure rules based on the types of records involved • Your attorney’s role The …
Read More
Ullman Quoted on Labeling Calories in Sports Nutrition Products
July 7, 2021 | Compliance Investigations & White Collar
Marc Ullman was quoted in the article, “Experts offer clarity on labeling calories for non-macronutrients.” The article focuses on the citizen’s petition filed by the Natural Products Association regarding the labeling of calories from branched chain amino acids. Ullman explained that there are some issues with the regulation. “There’s no way to put these …
Read More
Ullman Quoted on FTC’s “Made in the USA” Rule
July 6, 2021 | Compliance Investigations & White Collar
Marc Ullman commented in the article, “FTC finalizes ‘Made in the USA’ rule.” According to the article, the Federal Trade Commission has issued its final ‘Made in the USA’ rule about how companies can make this claim on their packaging and in advertising. In regards to dietary supplements, “Made in the USA claims continue …
Read More
Ullman Comments on FDA’s Handling of New Dietary Ingredients
July 1, 2021 | Compliance Investigations & White Collar
Marc Ullman was quoted in the NutraIngredients-USA article, “FDA lists NDI update among priorities for coming year.” The article discusses a list of priorities released yesterday by the US Food and Drug Administration (FDA), which included New Dietary Ingredients (NDI) Draft Guidance. “FDA’s entire handling of NDIs has been absurd,” Ullman said. “It seems to …
Read More
Kutner Discusses NPDB Reporting with Hospital Peer Review
June 30, 2021 | Health Services | Compliance Investigations & White Collar
Christopher J. Kutner was quoted extensively in the Hospital Peer Review article, “NPDB Reporting Protected by Law in Some Cases, Gray Areas Problematic.” The article discusses the protections afforded to hospitals that report doctors to the National Practitioner Data Bank (NPDB). The story also details the situations in which the protection may not be ironclad, …
Read More
Next Page

Get legal updates and news delivered to your inbox